Treatment of toxic epidermal, necrolysis in a pediatric patient with a nanocrystalline silver dressing

被引:43
作者
Asz, Jose [1 ,2 ]
Asz, Daniel [4 ]
Moushey, Robin [1 ,2 ]
Seigel, Jennifer [1 ,2 ]
Mallory, Susan B. [2 ,3 ]
Foglia, Robert P. [5 ]
机构
[1] St Louis Childrens Hosp, Div Pediat Surg & Pediat Acute Wound Serv, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] St Louis Childrens Hosp, Div Dermatol, St Louis, MO 63110 USA
[4] Hosp Gen Dr Manuel Gea Gonzalez, Dept Dermatol, Mexico City, DF, Mexico
[5] Childrens Med Ctr Dallas, Dept Pediat Surg, Dallas, TX USA
关键词
Toxic epidermal necrolysis (TEN); Stevens-Johnson syndrome (S[!text type='JS']JS[!/text]); Nanocrystalline silver dressing; Acticoat; Pediatric;
D O I
10.1016/j.jpedsurg.2006.08.043
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background/Purpose: To report a case of toxic epidermal necrolysis (TEN) involving 90% body surface area, successfully treated with a nanocrystalline silver dressing (Acticoat, Smith & Nephew, Largo, FL). Methods: A review of the hospital and acute wound center patient records and the recent English medical literature regarding TEN and nanocrystalline silver dressing. Results: We found only 1 report of TEN treated with a nanocrystalline silver dressing. The nanocrystalline silver dressing was both effective in preventing wound infection and convenient for treating our patient with TEN. Conclusion: The use of nanocrystalline silver dressing should be considered for the treatment of TEN. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:E9 / E12
页数:4
相关论文
共 15 条
[1]  
Clennett S, 2003, J Wound Care, V12, P151
[2]  
Demling RH, 2001, WOUNDS, V13, P4
[3]   DRUG-THERAPY - MANAGEMENT OF ACQUIRED BULLOUS SKIN DISEASES [J].
FINE, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1475-1484
[4]  
Lansdown A B G, 2002, J Wound Care, V11, P125
[6]   TOXIC EPIDERMAL NECROLYSIS (THE SCALDED SKIN SYNDROME) - REAPPRAISAL [J].
LYELL, A .
BRITISH JOURNAL OF DERMATOLOGY, 1979, 100 (01) :69-+
[7]   Dermatologic drug reactions [J].
McKenna, JK ;
Leiferman, KM .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (03) :399-+
[8]   A Multicenter review of toxic epidermal necrolysis treated in US burn centers at the end of the twentieth century [J].
Palmieri, TL ;
Greenhalgh, DG ;
Saffle, JR ;
Spence, PJ ;
Peck, MD ;
Jeng, JC ;
Mozingo, DW ;
Yowler, CJ ;
Sheridan, RL ;
Ahrenholz, DH ;
Caruso, DM ;
Foster, KN ;
Kagan, RJ ;
Voigt, DW ;
Purdue, GF ;
Hunt, JL ;
Wolf, S ;
Molitor, F .
JOURNAL OF BURN CARE & REHABILITATION, 2002, 23 (02) :87-96
[9]   New advances in severe adverse drug reactions [J].
Revuz, J .
DERMATOLOGIC CLINICS, 2001, 19 (04) :697-+
[10]   MEDICATION USE AND THE RISK OF STEVENS-JOHNSON SYNDROME OR TOXIC EPIDERMAL NECROLYSIS [J].
ROUJEAU, JC ;
KELLY, JP ;
NALDI, L ;
RZANY, B ;
STERN, RS ;
ANDERSON, T ;
AUQUIER, A ;
BASTUJIGARIN, S ;
CORREIA, O ;
LOCATI, F ;
MOCKENHAUPT, M ;
PAOLETTI, C ;
SHAPIRO, S ;
SHEAR, N ;
SCHOPF, E ;
KAUFMAN, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1600-1607